January 23, 2008 10:44 ET

Younger America Management Comments on the Company's Business

FORT LAUDERDALE, FL--(Marketwire - January 23, 2008) - (PINKSHEETS: YNGR)

To Our Shareholders:

I would first like to thank all of you for your continued support and faith in Younger America and wish everyone a healthy, happy and successful New Year. Last year Younger America successfully launched its first homeopathic product for a healthier lifestyle called the MEDLIGHT 630PRO. This product was designed and patented by NASA engineers and licensed to us for manufacturing and worldwide distribution. While 2007 was a year of growth for Younger America, our management team is even more excited about our growth prospects as we begin 2008 and begin to diversify our product suite offerings.

This past year the Management of Younger America has worked closely with Life Without Pain, LLC to successfully launch the MEDLIGHT 630PRO product. The consumer market demand during 2007 for the MEDLIGHT 630PRO exceeded our business plan due to our aggressive marketing tactics such as Home Shopping Network advertising. We believe that our product will continue to see increased demand in today's marketplace. Younger America has made great progress in grass roots marketing within the homeopathic medical community and is actively working with various insurance companies to seek reimbursements for the users of our product.

However, management does not believe that the current public valuation of Younger America common stock is indicative of the underlying value of the company's assets and growth prospects. Therefore, our management team will focus its time, efforts and resources to market the MEDLIGHT 630PRO as well as other products that fit within our corporate mission. In refocusing the resources to the product we sell, the Company will modify the Exchange agreement with Life Without Pain, LLC and not expose the shareholders to the costs associated with the acquisition and the Research, Development, and the Manufacturing. This will reduce expenses, obligations and exposure in 2008. Life Without Pain, LLC will assume all R&D and manufacturing costs going forward.

The strength of Younger America has always been in the marketing and point of sale of our products. Therefore, Younger America has entered into a definitive agreement with Life Without Pain, LLC to market both national and internationally the MEDLIGHT 630PRO and other homeopathic products. Younger America will maintain the websites, continue its marketing efforts for sales and product branding, and initiate an aggressive national infomercial program. Younger America will continue to market and brand the MEDLIGHT 630PRO while seeking additional products to add to its portfolio suite which fit the corporate mission of providing a "better way of life."

We believe that we are well positioned to take advantage of our target markets in 2008 and beyond. Our management team is committed to add shareholder value and we are very focused on increasing revenues by aggressively marketing our products while diversifying our product portfolio. In addition, we will review all available options to increase shareholder value and take the appropriate actions.

Thank you again for your support.

Sincerely,

Management and the Board of Directors

About Younger America:

Younger America is a holding Company that markets brands and sales products to improve the quality of life without the use of potentially harmful drugs or chemicals. The Company aims to represent a portfolio of products that provide leading-edge alternative medical devices, systems and services. The roll-up of these products will create value for the shareholders and provide innovative technologies and products that can enhance the quality of life for their customers.

Forward-Looking Statements:

Please be advised that statements made herein, other than historical data, constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. The potential risks and uncertainties include, among others, potential volatility in the Company's stock price, increased competition, customer acceptance of new products and services offered by the Company, and uncertainty of future revenue and profitability and fluctuations in its quarterly operating results. Please also be advised that the Company's stock is not currently registered with the Securities and Exchange Commission.